Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1013 Records) |
| Query Trace: Ovarian Neoplasms and BRCA2[original query] |
|---|
| Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2022 12 33 (2): 257-262. Marchetti Claudia, Ataseven Beyhan, Cassani Chiara, Sassu Carolina Maria, Congedo Luigi, D'Indinosante Marco, Cappuccio Serena, Rhiem Kerstin, Hahnen Eric, Lucci Cordisco Emanuela, Arbustini Eloisa, Harter Philipp, Minucci Angelo, Scambia Giovanni, Fagotti An |
| Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis. Annals of oncology : official journal of the European Society for Medical Oncology 2022 12 34 (2): 152-162. Labidi-Galy S I, Rodrigues M, Sandoval J L, Kurtz J E, Heitz F, Mosconi A M, Romero I, Denison U, Nagao S, Vergote I, Parma G, Nøttrup T J, Rouleau E, Garnier G, El-Balat A, Zamagni C, Martín-Lorente C, Pujade-Lauraine E, Fiévet A, Ray-Coquard I |
| BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 2022 12 58 (12): . Darabi Sourat, Braxton David R, Xiu Joanne, Carneiro Benedito A, Swensen Jeff, Antonarakis Emmanuel S, Liu Stephen V, McKay Rana R, Spetzler David, El-Deiry Wafik S, Demeure Michael |
| Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients. International journal of molecular sciences 2022 12 23 (24): . Gurioli Giorgia, Tedaldi Gianluca, Farolfi Alberto, Petracci Elisabetta, Casanova Claudia, Comerci Giuseppe, Danesi Rita, Arcangeli Valentina, Ravegnani Mila, Calistri Daniele, Zampiga Valentina, Cangini Ilaria, Fonzi Eugenio, Virga Alessandra, Tassinari Davide, Rosati Marta, Ulivi Paola, De Giorgi U |
| Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis. Frontiers in oncology 2022 12 12 1030786. Andrikopoulou Angeliki, Zografos Eleni, Apostolidou Kleoniki, Kyriazoglou Anastasios, Papatheodoridi Alksistis-Maria, Kaparelou Maria, Koutsoukos Konstantinos, Liontos Michalis, Dimopoulos Meletios-Athanasios, Zagouri Flo |
| Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases. Scientific reports 2022 11 12 (1): 20537. Duchnowska Renata, Supernat Anna Maria, P?ksa Rafa?, ?ukasiewicz Marta, Stokowy Tomasz, Ronen Roy, Dutkowski Janusz, Umi?ska Monika, I?ycka-?wieszewska Ewa, Kowalczyk Anna, Och Waldemar, Ruci?ska Monika, Olszewski Wojciech P, Mandat Tomasz, Jarosz Bo?ena, Bie?kowski Micha?, Biernat Wojciech, Jassem Jac |
| Germline multigene panel testing of patients with endometrial cancer. Oncology letters 2023 5 25 (6): 216. Jan Kral, Sandra Jelinkova, Petra Zemankova, Michal Vocka, Marianna Borecka, Leona Cerna, Marta Cerna, Lukas Dostalek, Petra Duskova, Lenka Foretova, Ondrej Havranek, Klara Horackova, Milena Hovhannisyan, Stepan Chvojka, Marta Kalousova, Marcela Kosarova, Monika Koudova, Vera Krutilkova, Eva Machackova, Petr Nehasil, Jan Novotny, Barbora Otahalova, Alena Puchmajerova, Marketa Safarikova, Jiri Slama, Viktor Stranecky, Ivan Subrt, Spiros Tavandzis, Michal Zikan, Tomas Zima, Jana Soukupova, Petra Kleiblova, Zdenek Kleibl, Marketa Janato |
| Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. JAMA oncology 2023 5 . Xuan Chen, Margaret A Meyer, Jennifer L Kemppainen, Masayasu Horibe, Shruti Chandra, Shounak Majumder, Gloria M Petersen, Kari G Ra |
| A New de novo BRCA1 Mutation in a Young Breast Cancer Patient: A Case Report. The application of clinical genetics 2023 5 16 83-87. Amina Scherz, Susanna Stoll, Benno Rothlisberger, Manuela Rabagl |
| Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis. Molecular oncology 2023 4 . Sun Zhe, Bai Chujie, Su Miaoyi, Tang Haimeng, Wu Xiaoying, Wang Yue, Bao Hua, Liu Xunbiao, Wu Xue, Shao Yang, Xu B |
| Targeted next-generation sequencing of 21 candidate genes in hereditary ovarian cancer patients from the Republic of Bashkortostan. Journal of ovarian research 2023 4 16 (1): 66. Prokofyeva D S, Mingazheva E T, Valova Ya V, Sakaeva D D, Faishanova R R, Nurgalieva A Kh, Valiev R R, Bogdanova N, Dörk T, Khusnutdinova E |
| Treatment of women with BRCA mutation. Climacteric : the journal of the International Menopause Society 2023 4 1-5. Depypere |
| The association between age at breast cancer diagnosis and prevalence of pathogenic variants. Breast cancer research and treatment 2023 4 . Mary B Daly, Eric Rosenthal, Shelly Cummings, Ryan Bernhisel, John Kidd, Elisha Hughes, Alexander Gutin, Stephanie Meek, Thomas P Slavin, Allison W Kuri |
| The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition. Cancer science 2023 4 . Yamazawa Kazuki, Sugano Kokichi, Tanakaya Kohji, Inoue Satomi, Murakami Haruka, Nakashima Moeko, Adachi Masataka, Oki Shinya, Makabe Takeshi, Yamashita Hiroshi, Ueki Arisa, Sasaoka Ayako, Nakashoji Ayako, Kinoshita Takayuki, Matsunaga Tatsuo, Arai Masami, Nakamura Seigo, Miyata Hiroaki, Ikegami Masachika, Mano Hiroyuki, Kohsaka Shinji, Matsui Aki |
| Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling. BMC cancer 2023 4 23 (1): 339. Melki Rahma, Melloul Marouane, Aissaoui Souria, El Harroudi Tijani, Boukhatem Noureddi |
| Genetic Analysis of Multiple Primary Malignant Tumors in Women with Breast and Ovarian Cancer. International journal of molecular sciences 2023 4 24 (7): . Savkova Alina, Gulyaeva Lyudmila, Gerasimov Aleksey, Krasil'nikov Serg |
| Germline Mutations Landscape in a Cohort of the State of Minas Gerais, Brazil, in Patients Who Underwent Genetic Counseling for Gynecological and Breast Cancer. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2023 3 45 (2): 74-81. Carvalho Camila Martins de, Braga Letícia da Conceição, Silva Luciana Maria, Chami Anisse Marques, Silva Filho Agnaldo Lopes |
| Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus blood. Clinical genetics 2023 3 . Schwartz Mathias, Moncoutier Virginie, Peytral Adrien, Le Gall Jessica, Suybeng Voreak, Pagès Mélanie, Masliah-Planchon Julien, Trabelsi-Grati Olfa, Melaabi Samia, Callens Céline, Bièche Ivan, Delhomelle Hélène, De Pauw Antoine, Saule Claire, Mouret-Fourme Emmanuelle, Gauthier-Villars Marion, Buecher Bruno, Colas Chrystelle, Stoppa-Lyonnet Dominique, Golmard Li |
| Frequency and distribution of BRCA1/BRCA2 large genomic rearrangements in Turkish population with breast cancer. Journal of human genetics 2023 3 . Akin Duman Tugba, Ozturk Fatma Nih |
| Ten-point guide on the management of healthy women carrying BRCA1/2 mutations. Maturitas 2023 3 171 21-23. Caretto Marta, Casula Elisa, Catrambone Ilaria, Giannini Andrea, Simoncini Tomma |
| Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis. Cancers 2023 3 15 (5): . Gaba Faiza, Blyuss Oleg, Tan Alex, Munblit Daniel, Oxley Samuel, Khan Khalid, Legood Rosa, Manchanda Ranj |
| Characterization of BRCA Deficiency in Ovarian Cancer. Cancers 2023 3 15 (5): . Barbero Giovanna, Zuntini Roberta, Magini Pamela, Desiderio Laura, Bonaguro Michela, Perrone Anna Myriam, Rubino Daniela, Grippa Mina, De Leo Antonio, Ceccarelli Claudio, Godino Lea, Miccoli Sara, Ferrari Simona, Santini Donatella, De Iaco Pierandrea, Zamagni Claudio, Innella Giovanni, Turchetti Danie |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
| [Pancreatic cancer screening in a clinical practice setting: it is the moment of Prevention]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru 2023 2 42 (4): 234-241. Adán-Merino Luisa, Mora-Soler Ana, Zaera-De la Fuente Celia, Garrido-Gallego Francisco, Crivillén-Anguita Olivia, Ponferrada-Diaz Áng |
| Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. Asian Pacific journal of cancer prevention : APJCP 2023 2 24 (2): 525-530. Sukpan Panupong, Kanokwiroon Kanyanatt, Sriplung Hutcha, Laochareonsuk Wison, Choochuen Pongsakorn, Auseng Nasuha, Wanawanakorn Kasemsun, Sangkhathat Suras |
| Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Frontiers in genetics 2023 2 14 1094260. Díaz-Velásquez Clara Estela, Gitler Rina, Antoniano Adriana, Kershenovich Sefchovich Ronny, De La Cruz-Montoya Aldo Hugo, Martínez-Gregorio Héctor, Rojas-Jiménez Ernesto Arturo, Cortez Cardoso Penha Ricardo, Terrazas Luis Ignacio, Wegman-Ostrosky Talia, Levi-Lahad Ephrat, Zabaleta Jovanny, Perdomo Sandra, Vaca-Paniagua Feli |
| Molecular Genetic Characteristics of FANCI, a Proposed New Ovarian Cancer Predisposing Gene. Genes 2023 2 14 (2): . Fierheller Caitlin T, Alenezi Wejdan M, Serruya Corinne, Revil Timothée, Amuzu Setor, Bedard Karine, Subramanian Deepak N, Fewings Eleanor, Bruce Jeffrey P, Prokopec Stephenie, Bouchard Luigi, Provencher Diane, Foulkes William D, El Haffaf Zaki, Mes-Masson Anne-Marie, Tischkowitz Marc, Campbell Ian G, Pugh Trevor J, Greenwood Celia M T, Ragoussis Jiannis, Tonin Patricia |
| Potential prognostic role of somatic mutations in a set of cancer susceptibility genes in ovarian carcinoma: A follow-up multicentric study from Pakistan. Cancer biomarkers : section A of Disease markers 2023 2 . Masood Atika, Sarfaraz Rahat, Zaki Saima, Shami Amira, Khaliq Saba, Naseem Nad |
| Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial. JCO precision oncology 2023 1 7 e2200258. Pujade-Lauraine Eric, Brown Jessica, Barnicle Alan, Wessen Jonathan, Lao-Sirieix Pierre, Criscione Steven W, du Bois Andreas, Lorusso Domenica, Romero Ignacio, Petru Edgar, Yoshida Hiroyuki, Vergote Ignace, Colombo Nicoletta, Hietanen Sakari, Provansal Magali, Schmalfeldt Barbara, Pignata Sandro, Martín Lorente Cristina, Berton Dominique, Runnebaum Ingo B, Ray-Coquard Isabel |
| Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 1 . Landen Charles N, Molinero Luciana, Hamidi Habib, Sehouli Jalid, Miller Austin, Moore Kathleen N, Taskiran Cagatay, Bookman Michael, Lindemann Kristina, Anderson Charles, Berger Regina, Myers Tashanna, Beiner Mario, Reid Thomas, Van Nieuwenhuysen Els, Green Andrew, Okamoto Aikou, Aghajanian Carol, Thaker Premal H, Blank Stephanie V, Khor Victor K, Chang Ching-Wei, Lin Yvonne G, Pignata Sand |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: